First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients
First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T [...]
Cancer awareness month – September, don’t forget to remember
The month of September represents the prostate cancer, thyroid cancer, [...]
ProsTIC – The new Centre of Excellence
Congratulations Peter MacCallum Cancer Centre for the launch of The Prostate [...]
Prostate Cancer Theranostics – An Overview
The implementation of theranostic approaches to characterize and personalize patient [...]
TheraP Trial Design in Prostate Cancer
Interesting interview with Pr. Michael Hofman about TheraP Trial Design [...]